Kidney Stones Clinical Trials

Find Kidney Stones Clinical Trials Near You

Randomized Single-Blind Cross-Over Trial Evaluating the Impact of Ureteral Stent Design on Bladder Spasms and Stent-Related Symptoms

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study will compare two commonly used ureteral stents in children and adolescents undergoing staged treatment for kidney stones. Ureteral stents are small tubes placed between the kidney and bladder to help urine drain after a procedure. Although stents are effective, they can cause bladder spasms, pain, urinary urgency, and other uncomfortable symptoms. Participants aged 8 to 18 years will receive both a standard Cook double-J ureteral stent and a Polaris Ultra ureteral stent during two planned procedures. The order in which the stents are used will be assigned at random, and participants and caregivers will not be told which stent is in place during each treatment period. Participants will report bladder spasms, pain, urinary symptoms, and quality of life through questionnaires and symptom assessments. The study will determine whether differences in stent design affect comfort, bladder spasms, urinary tract infections, or other stent-related complications. Both stents are approved by Health Canada and are used as part of routine clinical care.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 8
Maximum Age: 18
Healthy Volunteers: f
View:

• Ability of the participant and/or legally authorized representative to provide written informed consent, with assent obtained from the participant when appropriate, in accordance with institutional policy.

• Age 8 to 18 years at the time of enrollment.

• Undergoing staged ureteroscopic stone management requiring two sequential ureteral stent placements as part of standard clinical care.

• Planned placement of unilateral ureteral stents with an anticipated indwelling duration of approximately 4 to 6 weeks per stent.

• American Society of Anesthesiologists Physical Status Classification I or II at the time of surgery.

• Ability and willingness of the participant and/or caregiver to comply with study procedures, including completion of symptom assessments and questionnaires at specified time points.

• Ability to complete study questionnaires in English, either independently or with caregiver assistance.

Locations
Other Locations
Canada
SickKids
RECRUITING
Toronto
Contact Information
Primary
Michael Chua, MD
michael.chua@sickkids.ca
416-813-7654
Time Frame
Start Date: 2026-09-01
Estimated Completion Date: 2027-09-01
Participants
Target number of participants: 20
Treatments
Experimental: Polaris Ultra Followed by Cook Double-J
Participants assigned to this sequence will receive the Polaris Ultra ureteral stent during the first clinically indicated ureteroscopic procedure. At the subsequent staged procedure, the Polaris Ultra stent will be removed and participants will receive the Cook double-J ureteral stent for the second treatment period. Each stent will remain in place for approximately 4 to 6 weeks. Participants will complete symptom, pain, and quality-of-life assessments during both treatment periods.
Experimental: Cook Double-J Followed by Polaris Ultra
Participants assigned to this sequence will receive the Cook double-J ureteral stent during the first clinically indicated ureteroscopic procedure. At the subsequent staged procedure, the Cook stent will be removed and participants will receive the Polaris Ultra ureteral stent for the second treatment period. Each stent will remain in place for approximately 4 to 6 weeks. Participants will complete symptom, pain, and quality-of-life assessments during both treatment periods.
Sponsors
Leads: The Hospital for Sick Children

This content was sourced from clinicaltrials.gov